Regeneron Phar Dividend yield




   USD/share 
 Price  605.18
 Dividend  0.00
 Earnings  32.89
 Cash-flow  24.60
 Book value  102.57
 Equity  103.43

Regeneron Phar is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Regeneron Phar is a company from USA, and his stocks are publicly traded.

Regeneron Phar paid a total dividend of 0 million USD last year, for a market value of 63,544 millions (Market Cap 60,574 millions). Dividend per share of Regeneron Phar is 0.00 USD, and his stock market price 605.18 USD.

According to the chart below where dividend yield is displayed, Regeneron Phar, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from USA, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Regeneron Phar might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Regeneron Phar dividend yield with other Pharmaceuticals and Biotechnology companies or firms from USA.

Dividend yield of Regeneron Phar

Regeneron Phar Dividend Payout

About the ability of Regeneron Phar to maintain his current dividend of USD 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Regeneron Phar payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Regeneron Phar, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Regeneron Phar payout

Regeneron Phar Dividend History

Year Yield  USD  Paypout  Shares* 
Present0.00%0.000.00%105
20200.00%0.000.00%105
20190.00%0.000.00%108
20180.00%0.000.00%106
20170.00%0.000.00%106
20160.00%0.000.00%103
20150.00%0.000.00%102

*In millions

Regeneron Phar Stock performance

Finally, last moth Regeneron Phar showed a return of -10.10% compared to a worldwide -1.33% average, and a -3.33% of Health Care firms. Over the last year, the company obtained a 8.10% versus a worldwide performance of a 31.58%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.

Regeneron Phar stock and market return